Patents by Inventor Céline Monnet-Mars

Céline Monnet-Mars has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of modified Fc fragments in immunotherapy
    Patent number: 12247076
    Abstract: The present invention relates to the use of antibody Fc fragments in the treatment of autoimmune and/or inflammatory diseases, said Fc fragments being isolated recombinant Fc fragments having a modified affinity for at least one of the Fc receptors (FcR), particularly an increased affinity to FcRn.
    Type: Grant
    Filed: July 6, 2016
    Date of Patent: March 11, 2025
    Assignee: Laboratoire Français du Fractionnement et des Biotechnologies
    Inventors: Philippe Mondon, Céline Monnet-Mars, Alexandre Fontayne, Christophe De Romeuf, Abdessatar Chtourou
  • USE OF MODIFIED FC FRAGMENTS IN IMMUNOTHERAPY
    Publication number: 20180355034
    Abstract: The present invention relates to the use of antibody Fc fragments in the treatment of autoimmune and/or inflammatory diseases, said Fc fragments being isolated recombinant Fc fragments having a modified affinity for at least one of the Fc receptors (FcR), particularly an increased affinity to FcRn.
    Type: Application
    Filed: July 6, 2016
    Publication date: December 13, 2018
    Applicant: Laboratoire Français du Fractionnement et des Biotechnologies
    Inventors: Philippe Mondon, Céline Monnet-Mars, Alexandre Fontayne, Christophe De Romeuf, Abdessatar Chtourou